[Federal Register Volume 89, Number 46 (Thursday, March 7, 2024)]
[Notices]
[Pages 16590-16591]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04836]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on April 8-9, 2024. A sample of agenda items to be discussed
include: a review of recent medical events; a review of prescription
error reduction methods; and a review of several NRC draft licensing
guidance documents for the Eye90 microsphere device, the Akesis Galaxy
RTi unit, and the LV Liberty Vision Y-90 episcleral brachytherapy
source. The agenda is subject to change. The current agenda and any
updates will be available on the ACMUI's Meetings and Related Documents
web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html or by emailing Ms. L. Armstead at the contact
information below.
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Date and Time for Open Sessions: April 8, 2024, from 8:30 a.m. to
4:30 p.m. and April 9, 2024, from 10 a.m. to 12 p.m. eastern standard
time.
Address for Public Meeting: U.S. Nuclear Regulatory Commission, One
White Flint North Building (Commissioner's Hearing Room, O1-F16/O1-
G16), 11555 Rockville Pike, Rockville, Maryland 20852.
------------------------------------------------------------------------
Date Webinar information (Microsoft teams)
------------------------------------------------------------------------
April 8, 2024................ Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_NjllNmZkODktZTg3My00MDU0LTk4NzMtNjRhNmJlYmRmNGY 4NzMtNjRhNmJlYmRmNGY 1%40thread.v2/
0?context=%7b%22Tid%22%3a%22e8d01475-
c3b5-436a-a065-
5def4c64f52e%22%2c%22Oid%22%3a%22304f46b
f-32c2-4e0f-912c-878db895e74a%22%7d
Meeting ID: 257 264 946 630.
Passcode: n3TZmR.
[[Page 16591]]
Call in number (audio only): +301-576-
2978, Silver Spring.
Phone Conference ID: 954 210 683#.
------------------------------------------------------------------------
Public Participation: The meeting will be held in-person and as a
webinar using Microsoft Teams. Any member of the public who wishes to
participate in the meeting in person, via Microsoft Teams, or via phone
should contact Ms. L. Armstead using the information below. Members of
the public should also monitor the NRC's Public Meeting Schedule at
https://www.nrc.gov/pmns/mtg for any meeting updates.
Contact Information: Ms. L. Armstead, email: [email protected],
telephone: 301-415-1650.
Conduct of the Meeting
The ACMUI Chair, Hossein Jadvar, M.D., Ph.D., will preside over the
meeting. Dr. Jadvar will conduct the meeting in a manner that will
facilitate the orderly conduct of business. The following procedures
apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. L. Armstead using the contact information listed
above. All submittals must be received by the close of business on
April 2, 2024, and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chair.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html on or about May 24, 2024.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. L. Armstead of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily section 161a); the Federal Advisory
Committee Act (5 U.S.C. app); and the Commission's regulations in title
10 of the Code of Federal Regulations, part 7.
Dated at Rockville, Maryland this 4th day of March, 2024.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2024-04836 Filed 3-6-24; 8:45 am]
BILLING CODE 7590-01-P